Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Subjects With Renal Impairment”

637 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 637 results

Early research (Phase 1)Study completedNCT02729038
What this trial is testing

Pharmacokinetic Study of Gepotidacin in Subjects With Varying Degrees of Renal Impairment and in Subjects With Normal Renal Function

Who this might be right for
Infections, Bacterial
GlaxoSmithKline 32
Early research (Phase 1)Study completedNCT02039817
What this trial is testing

PK and PD Study of IDN-6556 in Subjects With Severe Renal Impairment and Matched Healthy Volunteers

Who this might be right for
Renal ImpairmentRenal InsufficiencyKidney Disease+1 more
Conatus Pharmaceuticals Inc. 16
Early research (Phase 1)Study completedNCT02063204
What this trial is testing

To Assess the Pharmacokinetics, Safety and Tolerability of Selumetinib in Renal Impaired Subjects and Healthy Subjects

Who this might be right for
Solid Tumours
AstraZeneca 24
Large-scale testing (Phase 3)Study completedNCT02892149
What this trial is testing

Efficacy and Safety Study to Evaluate Vadadustat for the Maintenance Treatment of Anemia in Participants With Dialysis-dependent Chronic Kidney Disease (DD-CKD)

Who this might be right for
AnemiaDialysis-Dependent Chronic Kidney Disease
Akebia Therapeutics 3,554
Early research (Phase 1)UnknownNCT02467790
What this trial is testing

Polyethylene Glycol Loxenatide Pharmacokinetics Study in Subjects With Normal and Insufficiency Renal Function

Who this might be right for
Type 2 Diabetes Mellitus
Jiangsu Hansoh Pharmaceutical Co., Ltd. 24
Early research (Phase 1)Study completedNCT00768404
What this trial is testing

Evaluate the Pharmacokinetics of VI-0521 Subjects With Renal Impairment

Who this might be right for
Renal Impairment
VIVUS LLC 32
Large-scale testing (Phase 3)WithdrawnNCT02015780
What this trial is testing

Fasiglifam in Type 2 Diabetic Subjects With Chronic Kidney Disease Stage 4 or 5 on Hemodialysis

Who this might be right for
Type 2 Diabetes MellitusChronic Kidney Disease
Takeda
Large-scale testing (Phase 3)Ended earlyNCT03710291
What this trial is testing

Evaluation of Effect of TRC101 on Progression of Chronic Kidney Disease in Subjects With Metabolic Acidosis

Who this might be right for
Metabolic AcidosisChronic Kidney Disease
Tricida, Inc. 1,480
Early research (Phase 1)Study completedNCT00641589
What this trial is testing

Determine the Pharmacokinetic and Pharmacodynamic Profiles of PROCRIT (Epoetin Alfa) in Anemic Patients With Chronic Kidney Disease

Who this might be right for
Chronic Kidney DiseaseAnemia
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 40
Early research (Phase 1)Study completedNCT02341599
What this trial is testing

Study of Pharmacokinetics of a Single IV Dose of CB-238,618 in Subjects With Varying Degrees of Renal Impairment Compared to Healthy Subjects (MK-6183-001)

Who this might be right for
Healthy VolunteersRenal Impairment
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 40
Testing effectiveness (Phase 2)Study completedNCT06150924
What this trial is testing

Efficacy and Safety of Lorundrostat in Addition to Sodium-Glucose Cotransporter-2 Inhibitors (SGLT2i) in Subjects With Hypertension and Chronic Kidney Disease (CKD) With Albuminuria

Who this might be right for
Chronic Kidney Disease
Mineralys Therapeutics Inc. 60
Testing effectiveness (Phase 2)Study completedNCT01999582
What this trial is testing

Intravenous or Subcutaneous Dosing of Sotatercept (ACE-011) in Patients With End-Stage Kidney Disease on Hemodialysis

Who this might be right for
AnemiaKidney Failure, Chronic
Celgene 50
Early research (Phase 1)Study completedNCT01266980
What this trial is testing

Assess the Effects of Repeat Doses of Fluticasone Furoate and GW642444M Combination in Healthy Subjects and in Subjects With Severe Impairment.

Who this might be right for
Pulmonary Disease, Chronic Obstructive
GlaxoSmithKline 18
Testing effectiveness (Phase 2)Ended earlyNCT01102218
What this trial is testing

A Safety Study of Pentoxifylline for the Treatment of Anemia

Who this might be right for
End Stage Renal Disease
Fresenius Medical Care North America 48
Large-scale testing (Phase 3)Study completedNCT03350347
What this trial is testing

Molidustat for Maintenance Treatment of Renal Anemia in Non-dialysis Subjects

Who this might be right for
AnemiaRenal Insufficiency, Chronic
Bayer 164
Testing effectiveness (Phase 2)Study completedNCT00810732
What this trial is testing

Effects Of Sitaxsentan On Proteinuria, 24-Hour Blood Pressure, And Arterial Stiffness In Chronic Kidney Disease Subjects

Who this might be right for
Chronic Kidney Disease
Pfizer 27
Early research (Phase 1)Study completedNCT01923857
What this trial is testing

Evaluation of Pharmacokinetic and Safety Profile of Androxal in Male Subjects With Impaired Renal Function

Who this might be right for
Secondary Hypogonadism
Repros Therapeutics Inc. 26
Testing effectiveness (Phase 2)Active Not RecruitingNCT06729853
What this trial is testing

PK and Safety Evaluation Study of SAP-001 in Adult Subjects With Normal and Impaired Renal Function

Who this might be right for
GoutHyperuricemia
Shanton Pharma Pte. Ltd. 32
Early research (Phase 1)Study completedNCT04486625
What this trial is testing

Pharmacokinetic Study of Aztreonam-Avibactam in Severe Renal Impairment

Who this might be right for
Renal Insufficiency
Pfizer 11
Large-scale testing (Phase 3)Study completedNCT01620489
What this trial is testing

Efficacy and Safety of Liraglutide Versus Placebo as add-on to Existing Diabetes Medication in Subjects With Type 2 Diabetes and Moderate Renal Impairment

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 279
Next Page